It was recently revealed that enhanced CXCL8 expression in the tumor microenvironment might also contribute to the local and systemic immunosuppression induced by glioblastoma [190], which allows GBMs to evade host immunosurveillance and may create a significant barrier to glioma immunotherapy. This evidence concerns the gene CXCL8 and glioblastoma.